Hikma d.o.o.
<b>Xellia Pharmaceuticals</b> is owned by Novo Holding A/S and is a specialty pharmaceutical company leading in the development, manufacture and supply of anti-infective treatments. Headquartered in Copenhagen, Denmark, Xellia has global facilities in Europe, North America, and Asia, currently employing over 1700 people. With over 100 years of industry experience in developing last resort treatments for infectious diseases, Xellia is focused on the supply of products which not only save lives, but also improve and enhance patients’ quality of life. Together with us, you can help lead the fight against bacterial infections.Plaće su porasle.
Pitanje je – gdje si ti u toj priči?
Odaberi najboljeg poslodavca i osvoji atraktivnu nagradu!
Dyson Airwrap, Električni romobil MS Energy, putovanje u St. Tropez i Azurnu obalu.
